Cabaletta Bio Inc (CABA)
11.81
-0.38
(-3.12%)
USD |
NASDAQ |
May 22, 16:00
11.82
+0.01
(+0.08%)
After-Hours: 20:00
Cabaletta Bio Cash from Investing (Quarterly): -0.812M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.812M |
| December 31, 2023 | 1.136M |
| September 30, 2023 | -0.065M |
| June 30, 2023 | -48.14M |
| March 31, 2023 | 24.62M |
| December 31, 2022 | -0.316M |
| September 30, 2022 | 23.91M |
| June 30, 2022 | -0.898M |
| March 31, 2022 | -49.91M |
| December 31, 2021 | 0.849M |
| September 30, 2021 | 1.77M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.027M |
| March 31, 2021 | 2.353M |
| December 31, 2020 | 1.891M |
| September 30, 2020 | 1.471M |
| June 30, 2020 | -11.12M |
| March 31, 2020 | -0.226M |
| December 31, 2019 | -0.273M |
| September 30, 2019 | -0.04M |
| June 30, 2019 | -0.20M |
| March 31, 2019 | -0.18M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-49.91M
Minimum
Mar 2022
24.62M
Maximum
Mar 2023
-2.649M
Average
-0.0525M
Median
Cash from Investing (Quarterly) Benchmarks
| Editas Medicine Inc | -4.745M |
| ACADIA Pharmaceuticals Inc | -14.04M |
| Alnylam Pharmaceuticals Inc | -67.62M |
| Regeneron Pharmaceuticals Inc | -1.687B |
| Vertex Pharmaceuticals Inc | -2.136B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.99M |
| Cash from Financing (Quarterly) | 6.855M |
| Free Cash Flow | -66.05M |
| Free Cash Flow Per Share (Quarterly) | -0.503 |
| Free Cash Flow Yield | -12.33% |